A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).
Clinical trial NCT05975905 · TERMINATED
Trial details
- NCT number
- NCT05975905
- Sponsor
- Keros Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-17
- Primary completion
- 2025-03-05
- Enrollment
- 113
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.